Despite the fact that costly immunotherapy drugs only help a small minority of patients, breast cancer doctors are calling the approval "tremendously exciting." In other pharmaceutical news: biologics and drugs for preventing premature births.
from Kaiser Health News https://ift.tt/2J4bB0J
March 11, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
An Arm and a Leg: To Get Health Insurance, This Couple Made a MovieLast fall, Ellen Haun and Dru Johnston were hustling to get their health insurance sorted out for 2023. The Hollywood couple are members of SAG-AFTRA, the union representing actors and writers. Members have to earn about $26,… Read More
FTC Chief Gears Up for a Showdown With Private EquityA recent Federal Trade Commission civil lawsuit accusing one of the nation’s largest anesthesiology groups of monopolistic practices that sharply drove up prices is a warning to private equity investors that could temper thei… Read More
‘Forever Chemicals’ in Thousands of Private Wells Near Military Sites, Study FindsWater tests show nearly 3,000 private wells located near 63 active and former U.S. military bases are contaminated with “forever chemicals” at levels higher than what federal regulators consider safe for drinking. According t… Read More
Uncle Sam Wants You … to Help Stop Insurers’ Bogus Medicare Advantage Sales TacticsAfter an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare Advantage and drug plans, the Biden administration hopes to unleash a special weapon to make sure companies follow the new… Read More
Hospitals and Doctors Are Fed up With Medicare AdvantageMedicare Advantage plans are pretty popular with both lawmakers and ordinary Americans — they now enroll about 31 million people, representing just over half of everyone in Medicare, by KFF’s count. But among doctors and hosp… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment